Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Non Operating Income (2017 - 2026)

Organogenesis Holdings has reported Non Operating Income over the past 9 years, most recently at $2.2 million for Q4 2025.

  • For Q4 2025, Non Operating Income rose 8185.19% year-over-year to $2.2 million; the TTM value through Dec 2025 reached $3.4 million, up 16700.0%, while the annual FY2025 figure was $2.3 million, 11280.0% up from the prior year.
  • Non Operating Income for Q4 2025 was $2.2 million at Organogenesis Holdings, up from $433000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $2.2 million in Q4 2025 and troughed at -$3.4 million in Q3 2021.
  • A 5-year average of -$119200.0 and a median of -$18000.0 in 2021 define the central range for Non Operating Income.
  • On a YoY basis, Non Operating Income climbed as much as 22822.22% in 2022 and fell as far as 24566.67% in 2022.
  • Year by year, Non Operating Income stood at -$9000.0 in 2021, then skyrocketed by 22822.22% to $2.0 million in 2022, then fell by 18.68% to $1.7 million in 2023, then plummeted by 101.62% to -$27000.0 in 2024, then soared by 8185.19% to $2.2 million in 2025.
  • Business Quant data shows Non Operating Income for ORGO at $2.2 million in Q4 2025, $433000.0 in Q3 2025, and $742000.0 in Q2 2025.